{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:45:10Z","timestamp":1793335510519,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.eclinm.2021.101145","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T22:59:49Z","timestamp":1633042789000},"page":"101145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study"],"prefix":"10.1016","volume":"41","author":[{"given":"Xi-Xi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah-Kheong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Kassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-2631","authenticated-orcid":false,"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eclinm.2021.101145_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101145_bib0002","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101145_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101145_bib0004","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"Journal of hepatology"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101145_bib0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.eclinm.2021.101145_bib0006","unstructured":"Health USDo, Control HSCfD, Statistics PNCfH. National Health and Nutrition Examination Survey III, 1988-1994. Inter-university Consortium for Political and Social Research [distributor]; 1998."},{"issue":"3","key":"10.1016\/j.eclinm.2021.101145_bib0007","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101145_bib0008","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101145_bib0009","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/apt.16487","article-title":"Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease","volume":"54","author":"Zhou","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101145_bib0010","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101145_bib0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41575-019-0239-2","article-title":"What\u2019s new in NAFLD pathogenesis, biomarkers and treatment?","volume":"17","author":"Byrne","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11-12","key":"10.1016\/j.eclinm.2021.101145_bib0012","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1365-2036.2010.04480.x","article-title":"A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients","volume":"32","author":"Anty","year":"2010","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101145_bib0013","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.eclinm.2021.101145_bib0014","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"Journal of lipid research"},{"key":"10.1016\/j.eclinm.2021.101145_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","article-title":"Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Poynard","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101145_bib0016","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/liv.13612","article-title":"Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study","volume":"38","author":"Younes","year":"2018","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.eclinm.2021.101145_bib0017","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s11695-008-9506-y","article-title":"A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)","volume":"18","author":"Younossi","year":"2008","journal-title":"Obes Surg"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101145_bib0018","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11695-010-0204-1","article-title":"A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis","volume":"21","author":"Younossi","year":"2011","journal-title":"Obes Surg"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101145_bib0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10408368409167137","article-title":"Measurement of aminotransferases: Part 1. Aspartate aminotransferase","volume":"21","author":"Rej","year":"1984","journal-title":"Critical reviews in clinical laboratory sciences"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101145_bib0020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","article-title":"Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method","volume":"37","author":"Heymsfield","year":"1983","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101145_bib0021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.02870707","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101145_bib0022","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","article-title":"Urea cycle dysregulation in non-alcoholic fatty liver disease","volume":"69","author":"De Chiara","year":"2018","journal-title":"Journal of hepatology"},{"key":"10.1016\/j.eclinm.2021.101145_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2019.10.025","article-title":"Creatinine: From physiology to clinical application","volume":"72","author":"Kashani","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101145_bib0024","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/liv.14251","article-title":"PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels","volume":"40","author":"Sun","year":"2020","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.eclinm.2021.101145_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101145_bib0026","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101145_bib0027","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.eclinm.2021.101145_bib0028","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/dc14-1239","article-title":"Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD","volume":"38","author":"Bazick","year":"2015","journal-title":"Diabetes Care"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:09:39Z","timestamp":1762888179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021004259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"alternative-id":["S2589537021004259"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101145","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101145"}}